Macrotrials provides a hub‑and‑spoke clinical trial platform that centralizes site setup, regulatory, budgeting, and quality oversight while leveraging a network of community‑based investigators in ophthalmology, dermatology, and pulmonology. By embedding coordinators at each site, the company accelerates activation to weeks, delivers predictable enrollment across diverse U.S. populations, and ensures high‑quality data for Phase 2 and later pharmaceutical, biotech, and CRO studies.
Funding
$6M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
3OFounders
Product
Problem
Pharmaceutical sponsors and CROs often face delays and high costs when activating clinical trial sites, especially in community settings where patient populations are diverse but infrastructure and operational support are limited. Traditional academic sites can be overburdened, leading to unpredictable enrollment timelines and variable data quality.
Solution
Macrotrials offers a hub‑and‑spoke model that centralizes trial setup, regulatory coordination, budgeting, and quality oversight while leveraging a network of community‑based investigators in ophthalmology, dermatology, and pulmonology. By embedding dedicated coordinators at each spoke site, Macro accelerates site activation to a matter of weeks, maintains consistent protocol discipline, and provides real‑time performance monitoring. The centralized hub delivers standardized workflows, equipment procurement, and vendor management, ensuring high‑quality data across geographically dispersed locations. This approach gives sponsors predictable enrollment rates, access to patient populations often missed by academic centers, and a scalable solution for Phase 2 and later studies.
Target Audience
Primary customers are pharmaceutical companies, biotech firms, and CROs seeking efficient, high‑quality enrollment for Phase 2 and later therapeutic or device trials, as well as community clinicians who wish to participate in research without added administrative load.
Features
- Centralized hub handling contracting, budgeting, IRB submissions, equipment procurement, and SOP standardization
- Embedded Macro coordinators at community‑based spoke sites to manage day‑to‑day trial operations
- Real‑time monitoring and quality oversight across all sites to ensure protocol compliance and data integrity
- Multilingual patient support and local access to treatment‑naïve, hard‑to‑reach populations
- Fast, predictable site startup within weeks, reducing overall trial timelines
- End‑to‑end operational delivery that removes administrative burden from investigators